Noven Pharmaceuticals Inc. Appoints Michael D. Price Chief Financial Officer

MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the appointment of Michael D. Price as vice president and chief financial officer, effective November 19, 2007, succeeding Diane M. Barrett, who is retiring at year-end.

MORE ON THIS TOPIC